by Ubaka Ogbogu | Jan 13, 2011
A couple of significant updates to report on from the ethics and law arena: On December 22, 2010, the Supreme Court of Canada (SCC) released its long-awaited judgment in the Reference re: Assisted Human Reproduction Act case involving a constitutional challenge...
by Stem Cell Network | Jan 12, 2011
In an article in the Globe and Mail this past weekend, reporter Carolyn Abraham provided an interesting and under-reported glimpse into the cosmetics industry use of stem cells to market their products. She notes: “In science, ‘stem cell’ has been...
by Ubaka Ogbogu | Jan 4, 2011
In March 2009, in his remarks at the signing of an Executive Order to reverse the Bush-era stem cell research funding restrictions, President Obama directed John P. Holdren, Director of the Office of Science and Technology Policy, to “develop a strategy for restoring...
by Ubaka Ogbogu | Dec 16, 2010
President Obama’s Commission on the Study of Bioethical Issues today released a report of its ethical investigation and recommendations for oversight of the emerging field of synthetic biology. The report responds to a charge to the Commission issued by the President...
by Ubaka Ogbogu | Dec 16, 2010
Chris Kamel’s recent post on chemically derived transcription factors for iPS cell production is very exciting for a variety of non-scientific reasons. Most notably, the innovative procedure and future improvements are likely to ease ethical, safety and legal concerns...
by Michelle Ly | Nov 29, 2010
I was having my bathroom renovated a few months ago and got into a discussion with my contractor about work. I mentioned that I had done some work with the BC Cancer Research Centre and other biomedical research institutes. His comment was, “Cancer research? So do you...
Comments